Mr. Steve Loutskou reports

RESTART LIFE SCIENCES APPOINTS CAPITAL MARKETS VETERAN LINDSAY HAMELIN TO BOARD OF DIRECTORS

Restart Life Sciences Corp. has appointed Lindsay Hamelin as an independent director of the company, effective immediately.

Ms. Hamelin brings over 20 years of capital markets and corporate finance experience, with a specific expertise in corporate structuring, mergers and acquisitions (M&A), and financing strategies within public company environments. Throughout her career, she has supported and advised public issuers on complex transactions, capital raises and strategic corporate development initiatives designed to support growth and enhance shareholder value.

Her extensive experience includes structuring and executing a wide range of financing transactions, including equity offerings and strategic capital initiatives, as well as advising on corporate reorganizations and M&A activity. Ms. Hamelin has worked closely with management teams on aligning corporate structures with long-term strategic objectives and capital markets execution.

"We are very pleased to welcome Lindsay to the board," said Steve Loutskou, chief executive officer of Restart Life. "Her 20-year track record in capital markets and M&A provides us with the high-level oversight needed for our next phase of strategic growth. Her perspective will be highly valuable as we continue to evaluate strategic opportunities and execute on our expansion within the better-for-you functional food and CPG [consumer packaged goods] markets."

Ms. Hamelin's appointment further strengthens Restart Life's board as the company continues to advance its growth strategy, with a focus on disciplined capital allocation, corporate development, and expansion within its portfolio of brands and intellectual property.

Restart Life Sciences would like to thank its shareholders for their continuing support as the company advances its mission and continues to execute on its strategy.

About Restart Life Sciences Corp.

Restart Life Sciences is a Canadian-based life sciences company listed on the Canadian Securities Exchange.

We seek Safe Harbor.